Movement Alert|Marvell Technology Overnight Rise 3.06%, Multiple Institutions Raise Target Prices Ahead of Earnings

Market Focus
Yesterday

On August 25, Marvell Technology rose 3.06% overnight, trading at $236.27/share, with turnover of $26.87 million, as the stock rebounded from consecutive sessions of profit-taking following its Google partnership rally.

On the news front, Wells Fargo significantly raised its price target on Marvell from $240 to $310, while Morgan Stanley lifted its target from $195 to $224. These upgrades follow earlier target price increases from UBS (to $310), Oppenheimer (to $300), and Citi (to $275), bringing the analyst consensus mean target to $277.37 — well above the current trading level. The wave of bullish calls reflects institutional confidence in the company's expanding AI data center and custom ASIC business lines, particularly following its landmark supply agreement with Google for TPU-related custom chips.

The company is scheduled to report fiscal Q2 results on August 27 after market close. Consensus estimates project quarterly revenue of approximately $2.707 billion, representing 34.74% year-over-year growth. RBC Capital Markets expects a slight beat and a 2-4% guidance raise for Q3, driven primarily by the Optical segment. Funds appear to be positioning ahead of the report after several days of pullback.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10